(Q35009181)

5 August 2017

1 reference

title

Sibutramine lost and found (English)

1 reference

5 August 2017

1 reference

Bosello O

1

1 reference

5 August 2017

Carruba MO

series ordinal

2

1 reference

5 August 2017

Ferrannini E

series ordinal

3

1 reference

5 August 2017

Rotella CM

series ordinal

4

1 reference

5 August 2017

1 September 2002

1 reference

Eating and Weight Disorders

5 August 2017

1 reference

5 August 2017

7

1 reference

5 August 2017

3

1 reference

5 August 2017

161-167

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03327453

5 August 2017

0 references

cites work

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

12 December 2020

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

1 reference

12 December 2020

Clinical evaluation of sibutramine in obese type 2 diabetic patients refractory to dietary management.

1 reference

12 December 2020

The importance of obesity in diabetes and its treatment with sibutramine

1 reference

12 December 2020

Body mass index and the prevalence of hypertension and dyslipidemia

1 reference

12 December 2020

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

1 reference

12 December 2020

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial

1 reference

12 December 2020

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee

1 reference

12 December 2020

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial

1 reference

12 December 2020

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

12 December 2020

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

1 reference

12 December 2020

Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy

1 reference

12 December 2020

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

12 December 2020

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity

1 reference

12 December 2020

Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.

1 reference

12 December 2020

Patterns of long-term weight changes in overweight developing Danish men and women aged between 30 and 60 years

1 reference

12 December 2020

An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action

1 reference

12 December 2020

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

1 reference

12 December 2020

Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over

1 reference

12 December 2020

Obesity: a rational target for managing diabetes mellitus

1 reference

12 December 2020

Childhood obesity: the health issue

1 reference

12 December 2020

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo.

1 reference

12 December 2020

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

1 reference

12 December 2020

The benefits of modest weight loss in type II diabetes

1 reference

12 December 2020

Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women

1 reference

12 December 2020

Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Body Weight and Mortality among Women

1 reference

12 December 2020

Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity

1 reference

12 December 2020

Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet--exercise intervention

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia

1 reference

12 December 2020

Pharmacotherapy for obesity -- do the benefits outweigh the risks?

1 reference

12 December 2020

An open-label trial of sibutramine in obese patients with binge-eating disorder.

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Long-term weight loss with sibutramine: a randomized controlled trial

1 reference

12 December 2020

Managing overweight and obese patients with particular reference to the use of drugs. Commentary on a Report of a Working Party of the Royal College of Physicians [report withdrawn]

1 reference

12 December 2020

When, for whom and how to use sibutramine?

1 reference

12 December 2020

Sibutramine in overweight/obese hypertensive patients

1 reference

12 December 2020

Type II diabetic subjects lose less weight than their overweight nondiabetic spouses

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03327453

1 reference

5 August 2017

1 reference